Additionally, GHK-Cu has demonstrated antimetastatic properties in research settings, adding to its range of observed biological effects
The FDA has noted both the lack of human clinical trial data and uncertainty about long-term safety
These peptides may come up in conversations with patients who are looking for support with: Slow recovery from workouts Soft tissue irritation General aches related to training or activity Mobility concerns Physical resilience Wellness optimization Healthy aging goals Recovery after stress, burnout, or overtraining However, symptoms like pain, swelling, weakness, digestive issues, fatigue, and reduced mobility should not be dismissed as simple recovery problems. They may indicate an underlying injury, inflammatory condition, hormonal issue, nutritional deficiency, sleep disorder, medication effect, or medical condition that needs proper evaluation
Another study, published in the American Journal of Ophthalmology, used health records from over 37 million people and found that GLP-1 drugs nearly doubled the five-year risk of developing optic nerve damage